Zoetis Inc (ZTS)
151.99
-1.03
(-0.67%)
USD |
NYSE |
Apr 17, 16:00
151.99
0.00 (0.00%)
After-Hours: 20:00
Zoetis Debt to Equity Ratio: 1.314 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.314 |
September 30, 2023 | 1.291 |
June 30, 2023 | 1.418 |
March 31, 2023 | 1.460 |
December 31, 2022 | 1.794 |
September 30, 2022 | 1.408 |
June 30, 2022 | 1.435 |
March 31, 2022 | 1.412 |
December 31, 2021 | 1.451 |
September 30, 2021 | 1.409 |
June 30, 2021 | 1.654 |
March 31, 2021 | 1.759 |
December 31, 2020 | 1.910 |
September 30, 2020 | 2.137 |
June 30, 2020 | 2.580 |
March 31, 2020 | 2.348 |
December 31, 2019 | 2.381 |
September 30, 2019 | 2.407 |
June 30, 2019 | 2.674 |
March 31, 2019 | 2.781 |
December 31, 2018 | 2.953 |
September 30, 2018 | 3.041 |
June 30, 2018 | 2.515 |
March 31, 2018 | 2.528 |
December 31, 2017 | 2.798 |
Date | Value |
---|---|
September 30, 2017 | 2.867 |
June 30, 2017 | 2.664 |
March 31, 2017 | 2.777 |
December 31, 2016 | 3.005 |
September 30, 2016 | 2.818 |
June 30, 2016 | 3.293 |
March 31, 2016 | 3.835 |
December 31, 2015 | 4.558 |
September 30, 2015 | 2.957 |
June 30, 2015 | 3.101 |
March 31, 2015 | 2.852 |
December 31, 2014 | 2.770 |
September 30, 2014 | 2.677 |
June 30, 2014 | 2.90 |
March 31, 2014 | 3.396 |
December 31, 2013 | 3.890 |
September 30, 2013 | 4.332 |
June 30, 2013 | 4.565 |
March 31, 2013 | 5.142 |
December 31, 2012 | 0.1446 |
September 30, 2012 | 0.1417 |
June 30, 2012 | 0.1464 |
March 31, 2012 | 0.1472 |
December 31, 2011 | 0.1546 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.291
Minimum
Sep 2023
2.674
Maximum
Jun 2019
1.802
Average
1.654
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Biogen Inc | 0.4688 |
Eli Lilly and Co | 2.342 |
Pfizer Inc | 0.7959 |
Abbott Laboratories | 0.3803 |
Bristol-Myers Squibb Co | 1.351 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 14.29B |
Total Liabilities (Quarterly) | 9.295B |
Shareholders Equity (Quarterly) | 4.997B |
Current Ratio | 3.358 |
Net Debt Paydown Yield | -0.00% |